Enhanced magnetic resonance imaging of experimental pancreatic tumor in vivo by block copolymer-coated magnetite nanoparticles with TGF-β inhibitor

Journal of Controlled Release

Volumn 140, Issue 3, 2009, Pages 306-311

  Kumagai, Michiaki ^a,d   Kano, Mitsunobu R ^a,b   Morishita, Yasuyuki ^b   Ota, Motomi ^a   Imai, Yutaka ^a   Nishiyama, Nobuhiro ^a,d   Sekino, Masaki ^a   Ueno, Shoogo ^c   Miyazono, Kohei ^a,b   Kataoka, Kazunori ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Magnetic resonance imaging; Magnetite nanoparticles; Pancreatic cancer; Poly(ethylene glycol); TGF

Indexed keywords

BLOOD CIRCULATION; CARBOXYLIC ACID GROUPS; CELL LINES; COATED NANOPARTICLES; CONTRAST AGENT; EARLY DETECTION; FETAL BOVINE SERUM; IN-VIVO; IRON OXIDE NANOPARTICLE; MAGNETITE NANOPARTICLES; NARROW DISTRIBUTION; NUDE MICE; PANCREATIC CANCERS; PANCREATIC TUMORS; POLY(ASPARTIC ACID); SOLID CANCER; SOLID TUMORS; TUMOR TISSUES;

BLOCK COPOLYMERS; CARBOXYLIC ACIDS; CARDIOVASCULAR SYSTEM; CELL CULTURE; COPOLYMERIZATION; ETHYLENE; ETHYLENE GLYCOL; FLUORINE CONTAINING POLYMERS; IONIC STRENGTH; IRON OXIDES; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; MAGNETITE; MEDICAL IMAGING; NANOPARTICLES; ORGANIC ACIDS; OXIDE MINERALS; PLASTIC COATINGS; POLYETHYLENE OXIDES; TUMORS;

POLYETHYLENE GLYCOLS;

CARBOXYLIC ACID; COPOLYMER; IRON OXIDE; MAGNETITE NANOPARTICLE; NANOPARTICLE; POLY(ETHYLENE GLYCOL) POLY(ASPARTIC ACID) COPOLYMER; PROTEIN INHIBITOR; TRANSFORMING GROWTH FACTOR BETA INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CHELATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VIVO STUDY; IONIC STRENGTH; MATERIAL COATING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PANCREAS ADENOCARCINOMA; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; FEMALE; FERROSOFERRIC OXIDE; HUMANS; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; LIGHT; MAGNETIC RESONANCE IMAGING; MAGNETICS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; PANCREATIC NEOPLASMS; POLYETHYLENE GLYCOLS; SCATTERING, RADIATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 70449719188     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.06.002     Document Type: Article

References (21)

1. Dreher M.R., Liu W., Michelich C.R., Dewhirst M.W., Yuan F., and Chilkoti A. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J. Natl. Cancer Inst. 98 5 (2006) 335-344
2. Burris H.A., Moore M.J., Andersen J., Green M.R., Rothenberg M.L., Modiano M.R., Cripps M.C., Portenoy R.K., Storniolo A.M., Tarassoff P., Nelson R., Dorr F.A., Stephens C.D., and Von Hoff D.D. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. 15 6 (1997) 2403-2413
3. Sahani D.V., Shah Z.K., Catalano O.A., Boland G.W., and Brugge W.R. Radiology of pancreatic adenocarcinoma: current status of imaging. J. Gastroenterol. Hepatol. 23 1 (2008) 23-33
4. Huber D.L. Synthesis, properties, and applications of iron nanoparticles. Small 1 5 (2005) 482-501
5. Weissleder R., Elidonzo G., Wittenberg J., Rabito C.A., Bengele H.H., and Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175 2 (1990) 489-493
6. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., and Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18 4 (2000) 410-414
7. Jun Y.W., Lee J.H., and Cheon J. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew. Chem. Int. Ed. 47 28 (2008) 5122-5135
8. Stark D.D., Weissleder R., Elizondo G., et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 168 2 (1988) 297-301
9. Neuberger T., Schöpf B., Hofmann H., Hofmann M., and von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Mater. 293 1 (2005) 483-496
10. Kumagai M., Imai Y., Nakamura T., Yamasaki Y., Sekino M., Ueno S., Hanaoka K., Kikuchi K., Nagano T., Kaneko E., Shimokado K., and Kataoka K. Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloids Surf. B: Biointerfaces 56 1-2 (2007) 174-181
11. Kano M.R., Bae Y., Iwata C., Morishita Y., Yashiro M., Oka M., Fujii T., Komuro A., Kiyono K., Kaminishi M., Hirakawa K., Ouchi Y., Nishiyama N., Kataoka K., and Miyazono K. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling. Proc. Natl. Acad. Sci. U. S. A. 104 9 (2007) 3460-3465
12. Matsumura Y., and Maeda H. A new concept for macromolecular therapeutics in cancer-chemotherapy-mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res. 46 12 (1986) 6387-6392
13. Nishiyama N., Yokoyama M., Aoyagi T., Okano T., Sakurai Y., and Kataoka K. Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichlorodiammineplatinum(II) and poly(ethylene glycol)-poly(alpha,beta-aspartic acid) block copolymer in an aqueous medium. Langmuir 15 2 (1999) 377-383
14. In: Fukushima E., and Roeder S.B.W. (Eds). Experimental pulse NMR: a nuts and bolts approach (1981), Addison-Wesley, Reading, Mass 28-35
15. MacFadzean A.J.S., and Davis L.J. Iron-staining erythrocytic inclusions with especial reference to acquired haemolytic anaemia. Glasgow Med. J. 28 (1947) 237-279
16. Takae S., Akiyama Y., Otsuka H., Nakamura T., Nagasaki Y., and Kataoka K. Ligand density effect on biorecognition by PEGylated gold nanoparticles: regulated interaction of RCA120 lectin with lactose installed to the distal end of tethered PEG strands on gold surface. Biomacromolecules 6 2 (2005) 818-824
17. Cromières L., Moulin V., Fourest B., and Giffaut E. Physico-chemical characterization of the colloidal hematite/water interface: experimentation and modeling. Colloids Surf., A. Physicochem. Eng. Asp. 202 1 (2002) 101-115
18. Kirwan L.J., Fawell P.D., and van Bronswijk W. In situ FTIR-ATR examination of poly(acrylic acid) adsorbed onto hematite at low pH. Langmuir 19 14 (2003) 5802-5807
19. Wang Y.X.J., Hussain S.M., and Krestin G.P. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11 11 (2001) 2319-2331
20. Wan S.R., Huang J.S., Guo M., Zhang H., Cao Y., Yan H., and Liuet K. Biocompatible superparamagnetic iron oxide nanoparticle dispersions stabilized with poly(ethylene glycol)oligo(aspartic acid) hybrids. J. Biomed. Mater. Res. A 80A 4 (2007) 946-954
21. Jung C.W. Surface-properties of superparamagnetic iron-oxide MR contrast agents - ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imaging 13 5 (1995) 675-691